NDC 70370-2040

INGREZZA

Valbenazine

INGREZZA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Neurocrine Biosciences, Inc.. The primary component is Valbenazine.

• Product ID: 70370-2040_043532a9-b5eb-4e93-80a8-fbb88e5e523d
• NDC: 70370-2040
• Product Type: Human Prescription Drug
• Proprietary Name: INGREZZA
• Generic Name: Valbenazine
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2018-12-14
• Marketing Category: NDA / NDA
• Application Number: NDA209241
• Labeler Name: Neurocrine Biosciences, Inc.
• Substance Name: VALBENAZINE
• Active Ingredient Strength: 40 mg/1
• Pharm Classes: Vesicular Monoamine Transporter 2 Inhibitor [EPC],Vesicular Monoamine Transporter 2 Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 70370-2040-1

30 CAPSULE in 1 BOTTLE (70370-2040-1)

• Marketing Start Date: 2018-12-14
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 70370-2040-1 [70370204001]

INGREZZA CAPSULE

• Marketing Category: NDA
• Application Number: NDA209241
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2018-12-14

Drug Details

Pharmacological Class

• Vesicular Monoamine Transporter 2 Inhibitor [EPC]
• Vesicular Monoamine Transporter 2 Inhibitors [MoA]

NDC Crossover Matching brand name "INGREZZA" or generic name "Valbenazine"

NDC	Brand Name	Generic Name
70370-1040	INGREZZA	Valbenazine
70370-1048	INGREZZA	Valbenazine
70370-1060	INGREZZA	Valbenazine
70370-1080	INGREZZA	Valbenazine
70370-2040	INGREZZA	Valbenazine
70370-2048	INGREZZA	Valbenazine